There are opportunities to be had in the biotechnology and pharmaceutical industries, but some investors shy away because of the “Sleep Factor”. Industry Focus host Kristine Harjes analyzes the drug approval process and why every investor should take a close look at this industry. She also shares two drugmaker stocks she likes right now, and introduces the term “bleeding event” to the conversation.
